Gilead to buy biotech firm Ouro Medicines in over $2 billion deal
Mar 23, 2026 3:51 PM
March 23 (Reuters) - Gilead Sciences ( GILD ) said on Monday it would buy privately held biotech firm Ouro Medicines in a deal worth up to $2.18 billion.
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations,
you may see comments from our Community Managers.